The Journal of Practical Medicine >
Study on the expression of PYCARD, RANKL and CHI3L1 in the serum of patients with rheumatoid arthritis and their relationship with disease activity
Received date: 2026-01-06
Online published: 2026-06-15
Objective To investigate the expression levels of apoptosis-associated speck-like protein (PYCARD), nuclear factor κB receptor activator ligand (RANKL), and chitinase 3-like protein 1 (CHI3L1) in the serum of patients with rheumatoid arthritis (RA), and to explore the relationship between these proteins and disease activity. Methods A total of 104 patients with rheumatoid arthritis (RA group) who were admitted to Anqing Municipal Hospital from January 2021 to December 2025 were recruited for this study. They were divided into the remission group (51 cases) and the active group (53 cases) based on the 28-joint disease activity score (DAS28). Additionally, 52 healthy volunteers (control group) were recruited during the same period. The expression levels of serum PYCARD, RANKL, and CHI3L1 were compared between the RA group and the control group, as well as between the remission group and the active group. Moreover, the correlation between the expression levels of these three markers and the DAS28 score was analyzed, along with the evaluation value of the combined detection of serum PYCARD, RANKL, and CHI3L1 for the disease activity of RA. Results In the RA group, the expression levels of serum PYCARD, RANKL, and CHI3L1 were significantly higher than those in the control group (P < 0.05). In the active group, the expression levels of serum PYCARD, RANKL, and CHI3L1 were significantly higher than those in the remission group (P < 0.05). The expression levels of serum PYCARD, RANKL, and CHI3L1 were positively correlated with the DAS28 score (r = 0.579, 0.534, 0.602, P < 0.05). The area under the curve (AUC) value of the combined detection of serum PYCARD, RANKL, and CHI3L1 for the evaluation of RA disease activity was 0.898. The AUC values of the three individual tests were 0.743, 0.730, and 0.767, respectively. The AUC value of the combined detection was significantly higher than those of the individual detections (P < 0.05). The sensitivity and specificity of the combined detection were 92.45% and 84.31%, respectively. Conclusions The expression levels of PYCARD, RANKL, and CHI3L1 are related to the onset of RA and its disease activity. The combined detection of PYCARD, RANKL, and CHI3L1 has the advantage of collaborative diagnosis and is of high value in evaluating the disease activity of RA, providing a more objective and accurate assessment method for the disease activity status of clinical RA patients.
Ran LI , Luyao WANG , Daiguo LU , Guihong WANG . Study on the expression of PYCARD, RANKL and CHI3L1 in the serum of patients with rheumatoid arthritis and their relationship with disease activity[J]. The Journal of Practical Medicine, 2026 , 42(11) : 1981 -1986 . DOI: 10.3969/j.issn.1006-5725.2026.11.012
| [1] | LIU Q, ZHANG Y. Biological Clock Perspective in Rheumatoid Arthritis[J]. Inflammation, 2025, 48(3): 1028-1041. doi: 10.1007/s10753-024-02120-4 . |
| [2] | BARRY S, SHENG E, BAKER JF. Metabolic Consequences of Rheumatoid Arthritis[J]. Arthritis Care Res (Hoboken), 2025, 77(10): 1167-1174. doi: 10.1002/acr.25537 . |
| [3] | 邹国强, 刘英, 王旭凤, 等. 类风湿性关节炎病情与牙周病原菌感染的关系研究进展[J]. 中国病原生物学杂志, 2024, 19(8): 990-993. doi:10.13350/j.cjpb.240826 . |
| [4] | NOTO G, SALVETTI F, DEMAJ A, et al. Pathogenesis of rheumatoid arthritis: one year in review 2025[J]. Clin Exp Rheumatol, 2025, 43(9): 1533-1540. doi: 10.55563/clinexprheumatol/53rkan . |
| [5] | 周晓娟, 龚翠婷, 张继云. 原发性干燥综合征患者的血清IL-38水平及其临床意义[J]. 暨南大学学报(自然科学与医学版), 2025, 46(2): 205-213. doi: 10.11778/j.jdxb.20240403 . |
| [6] | 于艳, 于程程, 韩亚琨. 牙周炎伴类风湿性关节炎患者牙龈浆细胞表型及RANKL表达特点分析[J]. 吉林大学学报(医学版), 2023, 49(3): 757-764. doi: 10.13481/j.1671-587X.20230326 . |
| [7] | GU S M, KIM T H, PARK J H, et al. Chitinase-3-Like Protein 1 as a Therapeutic Target for Inflammatory Diseases[J]. Biomol Ther (Seoul), 2025, 33(5): 747-757. doi: 10.4062/biomolther.2025.050 . |
| [8] | TIZAOUI K, YANG J W, LEE K H, et al. The role of YKL-40 in the pathogenesis of autoimmune diseases: A comprehensive review[J]. Int J Biol Sci, 2022, 18(9): 3731-3746. doi: 10.7150/ijbs.67587 . |
| [9] | 中华医学会风湿病学分会. 2018中国类风湿关节炎诊疗指南[J]. 中华内科杂志, 2018, 57(4): 242-251. doi: 10.3760/cma.j.issn.0578-1426.2018.04.004 . |
| [10] | 杨光月, 杜国庆, 潘富伟, 等. MicroRNA-93和TLR4在类风湿关节炎患者血清中的表达及临床意义[J]. 医学研究生学报, 2022, 35(11): 1166-1170. doi:10.16571/j.cnki.1008-8199. 2022.11.009 . |
| [11] | 中华人民共和国卫生部医政司. 全国临床检验操作规程[M]. 3版. 南京: 东南大学出版社, 2006: 126-137. |
| [12] | 李明哲, 陶江涛, 梁振新. 温针灸联合健脾通络方治疗对类风湿性关节炎患者炎症因子和骨代谢的影响[J]. 实用医学杂志, 2023, 39(10): 1305-1310. doi: 10.3969/j.issn.1006-5725. 2023.10.020 . |
| [13] | 张玉红, 单新洁, 周俊. miR-155通过SOCS1/STAT3途径调控类风湿性关节炎中炎症反应和Th17/Treg失衡[J]. 实用医学杂志, 2024, 40(13): 1791-1796. doi: 10.3969/j.issn.1006-5725.2024.13.005 . |
| [14] | KIM J W, JUNG J Y, SUH C H, et al. Comprehensive analysis of patients with rheumatoid arthritis associated interstitial lung disease[J]. Korean J Intern Med, 2025, 40(5): 845-855. doi: 10.3904/kjim.2024.377 . |
| [15] | RACHID ZAIM S, SAVAGE A K, GILLESPIE M A, et al. Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development[J]. Arthritis Rheumatol, 2025, 77(9): 1166-1178. doi: 10.1002/art.43175 . |
| [16] | SAHIN D, DI MATTEO A, EMERY P. Biomarkers in the diagnosis, prognosis and management of rheumatoid arthritis: A comprehensive review[J]. Ann Clin Biochem, 2025, 62(1): 3-21. doi: 10.1177/00045632241285843 . |
| [17] | WALTER W R, SAMIM M. Imaging Updates in Rheumatoid Arthritis[J]. Semin Musculoskelet Radiol, 2025, 29(2): 156-166. doi: 10.1055/s-0045-1802952 . |
| [18] | CHANG S H, PARK Y B, MCDERMOTT G C, et al. Serum Biomarkers of Pulmonary Damage and Risk for Progression of Rheumatoid Arthritis-Associated Interstitial Lung Disease[J]. J Rheumatol, 2025, 52(4): 323-333. doi: 10.3899/jrheum.2024-0713 . |
| [19] | GAMAL M, EL-DIWANY O, ELHAMED S S ABD, et al. Association of circulating Treg and plasma microRNA-21 with rheumatoid arthritis progression[J]. Egypt J Immunol, 2025, 32(1): 63-76. doi: 10.55133/eji.320107 . |
| [20] | SUGANUMA Y, TANAKA H, KAWASE A, et al. Expression of a PYCARD/ASC variant lacking exon 2 in Japanese patients with palindromic rheumatism increases interleukin-1β secretion[J]. Asian Pac J Allergy Immunol, 2022, 40(1): 81-86. doi: 10.12932/AP-040319-0509 . |
| [21] | WANG C, ZHANG H, WANG X, et al. Targeting BRD4 to attenuate RANKL-induced osteoclast activation and bone erosion in rheumatoid arthritis[J]. Mol Cell Biochem, 2025, 480(3): 1669-1684. doi: 10.1007/s11010-024-05073-2 . |
| [22] | WANG Y H, SU C H, CHEN L C, et al. miR-548aj-3p and miR-3127-3p suppress RANKL-facilitated inflammatory cytokines and catabolic factor in osteoarthritis and rheumatoid arthritis[J]. Int J Med Sci, 2025, 22(14): 3650-3663. doi: 10.7150/ijms.110812 . |
| [23] | MO H, SU Z H, ZHENG Z Y, et al. Screening for early rheumatoid arthritis using high-frequency ultrasound, serum RANKL, and OPG detection[J]. Clin Rheumatol, 2024, 43(1): 159-166. doi: 10.1007/s10067-023-06830-2 . |
| [24] | 卢瑾, 闻名, 唐情容, 等. 血清GP73、CHI3L1表达与慢性乙型肝炎患者肝纤维化及病理变化程度的关系[J]. 实用医学杂志, 2024, 40(11): 1586-1591. doi: 10.3969/j.issn.1006-5725. 2024.11.020 . |
| [25] | JIN Y, SONG J, XU F, et al. Association between YKL-40 and asthma: A systematic meta-analysis[J]. Sleep Breath, 2022, 26(3): 1011-1022. doi: 10.1007/s11325-021-02495-w . |
| [26] | COLMENARES V, HEDMAN A, HESSLOW A, et al. Cohort study of serological biomarkers for interstitial lung disease in patients with rheumatoid arthritis[J]. Scand J Rheumatol, 2024, 53(6): 386-395. doi: 10.1080/03009742.2024.2413238 . |
/
| 〈 |
|
〉 |